Palomino Laboratories (PALX) Notes Payables (2022 - 2025)

Palomino Laboratories recorded quarterly Notes Payables of $20000.0 in Q2 2025, up 536.94% quarter-over-quarter from $3140.0 in Q4 2024, and down 81.85% year-over-year from $110204.0 in Q2 2024.

Palomino Laboratories' Notes Payables history runs 4 years deep, the most recent figure standing at $20000.0 for Q2 2025.

  • In Q2 2025, Notes Payables fell 81.85% year-over-year to $20000.0; the TTM figure through Jun 2025 stood at $20000.0 (down 81.85% YoY), while the FY2024 annual figure was $3140.0, down 68.6% from the prior year.
  • Notes Payables came in at $20000.0 for Q2 2025 at Palomino Laboratories, up from $3140.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $130247.0 in Q3 2024 to a low of $304.0 in Q4 2022.
  • A 4-year average of $38492.8 and a median of $15625.0 in 2024 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables jumped 3189.47% in 2023 and slumped 81.85% in 2025, its largest moves.
  • Palomino Laboratories' Notes Payables stood at $304.0 in 2022, then surged by 3189.47% to $10000.0 in 2023, then plunged by 68.6% to $3140.0 in 2024, then soared by 536.94% to $20000.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $20000.0, $3140.0, and $130247.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 20,000.00
Mar 31, 2025 275,000.00
Dec 31, 2024 3,140.00
Sep 30, 2024 130,247.00
Jun 30, 2024 110,204.00
Mar 31, 2024 79,563.00
Dec 31, 2023 10,000.00
Sep 30, 2023 22,797.00
Dec 31, 2022 5,000.00